Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Celularity Inc (CELU) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Celularity Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1752828.
Total stock buying since 2021: $8,479,083.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $884,825.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 0 | $0 | 49,267 | $0 |
2024 | 21,410,983 | $5,331,334 | 0 | $0 | 0 | $0 |
2023 | 18,422,124 | $2,992,569 | 15,371,697 | $0 | 1,071,000 | $299,880 |
2022 | 90,000 | $155,180 | 0 | $0 | 887,667 | $556,945 |
2021 | 0 | $0 | 0 | $0 | 100,000 | $28,000 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2025-04 | 0 | $0 | 0 | $0 | 6,767 | $0 |
2025-02 | 0 | $0 | 0 | $0 | 42,500 | $0 |
2024-01 | 21,410,983 | $5,331,334 | 0 | $0 | 0 | $0 |
2023-10 | 9,357,585 | $1,487,856 | 6,307,158 | $0 | 0 | $0 |
2023-09 | 9,064,539 | $1,504,713 | 9,064,539 | $0 | 0 | $0 |
2023-02 | 0 | $0 | 0 | $0 | 1,071,000 | $299,880 |
2022-11 | 90,000 | $155,180 | 0 | $0 | 0 | $0 |
2022-08 | 0 | $0 | 0 | $0 | 887,667 | $556,945 |
2021-11 | 0 | $0 | 0 | $0 | 100,000 | $28,000 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-04-13 | Brigido Stephen (Pres., Functional Regeneration) | Option Ex | 820 | .00 | 0 |
2025-04-13 | Beers David C (Chief Financial Officer) | Option Ex | 1,025 | .00 | 0 |
2025-04-13 | Haines John R (Senior Exec Vice President) | Option Ex | 1,641 | .00 | 0 |
2025-04-13 | Hariri Robert J (Chief Executive Officer) | Option Ex | 3,281 | .00 | 0 |
2025-02-17 | Brigido Stephen (Pres., Functional Regeneration) | Option Ex | 10,000 | .00 | 0 |
2025-02-17 | Beers David C (Chief Financial Officer) | Option Ex | 12,500 | .00 | 0 |
2025-02-17 | Haines John R (Senior Exec Vice President) | Option Ex | 20,000 | .00 | 0 |
2024-01-12 | Genting Berhad | Buy | 21,410,983 | .25 | 5,331,334 |
2023-10-05 | Hariri Robert J (Chief Executive Officer) | Buy | 9,357,585 | .16 | 1,487,856 |
2023-10-05 | Sorrento Therapeutics, Inc. | Sale | 6,307,158 | .00 | 0 |
2023-09-29 | Hariri Robert J (Chief Executive Officer) | Buy | 9,064,539 | .17 | 1,504,713 |
2023-09-29 | Sorrento Therapeutics, Inc. | Sale | 9,064,539 | .00 | 0 |
2023-02-10 | Diamandis Peter (Director) | Option Ex | 1,071,000 | .28 | 299,880 |
2022-11-30 | Hariri Robert J (Chief Executive Officer) | Buy | 10,000 | 1.72 | 17,180 |
2022-11-29 | Hariri Robert J (Chief Executive Officer) | Buy | 40,000 | 1.71 | 68,400 |
2022-11-28 | Hariri Robert J (Chief Executive Officer) | Buy | 40,000 | 1.74 | 69,600 |
2022-08-26 | Sculley John (Director) | Option Ex | 768,594 | .28 | 215,206 |
2022-08-24 | Hariri Robert J (Chief Executive Officer) | Option Ex | 119,073 | 2.87 | 341,739 |
2021-11-09 | Von Eschenbach Andrew C. (Director) | Option Ex | 100,000 | .28 | 28,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CELU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Celularity Inc (symbol CELU, CIK number 1752828) see the Securities and Exchange Commission (SEC) website.